MedTrace Logo

HEAL Study: Healing Results, Efficacy and Acceptability of a New Contact Layer

NCT03640871 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2018-08-22

No results posted yet for this study

Summary

Assessment of efficacy, tolerance and acceptability for the wound dressing URGO AWC\_019 in the treatment of acute wounds, chronic wounds and epidermolysis bullosa skin lesions

Conditions

  • Wound

Interventions

DEVICE

URGO AWC_019 dressing (AWC=Advanced Wound Care)

URGO AWC\_019 dressing 10x10 cm (AWC=Advanced Wound Care)

Sponsors & Collaborators

  • Laboratoires URGO

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-31
Primary Completion
2019-11-30
Completion
2019-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03640871 on ClinicalTrials.gov